Track topics on Twitter Track topics that are important to you
Glasgow, Scotland, July 27, 2015 / B3C newswire / -- BioOutsource Ltd. (“BioOutsource”), part of Sartorius Stedim Biotech Group and a global leader in biologics contract testing and biosimilar characterisation for the biopharmaceutical industry, today announced the opening of a new facility which doubles BioOutsource’s capacity for future growth.
“Our opening of this new, state-of-the-art facility demonstrates our commitment to our growing list of global customers,” commented BioOutsource CEO, Gerry MacKay. “Demand for our services remains high and we are doubling our capacity to make sure we are ready to support the robust pipeline of biotech and biosimilar products currently in development.
It is estimated that in opening and running the new facility, BioOutsource will create approximately 50 new jobs for scientific and technical professionals in the next six months.
Mr. MacKay continued, “This is a great opportunity for Life Science professionals to join an exciting and rapidly growing company. With the recent acquisition by Sartorius Stedim Biotech we expect to become one of the largest employers in this sector in Scotland and further investment in new services is already planned”.
Caption: New facility in GlasgowFor high resolution please click the image
About BioOutsource Ltd
Now part of Sartorius Stedim Biotech Group, BioOutsource provides contract testing services to the biopharmaceutical industry. Our core offering includes a comprehensive range of services to support the testing of biologics, vaccines & biosimilars throughout their development. We possess an unparalleled combination of commercial, regulatory and technical knowledge that enables us to truly stand out as the industry’s increasingly preferred testing partner. We understand the importance of our service to support our client’s critical testing requirements and as a result, continually strive to provide a world class service globally.
+ 44 (0) 141 946 4222
Original Article: BioOutsource Opens New Facility in GlasgowNEXT ARTICLE
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...
Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product. Products that ar...
Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...